Bo‐Wei Han
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Reproductive Medicine top 5%
- Endometriosis Research and Treatment
Papers in
-
- Cancer-related molecular mechanisms research 7
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 4
-
- RNA modifications and cancer 3
- DNA Repair Mechanisms 2
- Circular RNAs in diseases 2
- Single-cell and spatial transcriptomics 2
- RNA Research and Splicing 2
- Co-authors
- Yujie Chen (8 shared papers)Wentao Wang (3 shared papers)Panpan Wei (5 shared papers)Xingju Zhang (4 shared papers)Hua Zhang (4 shared papers)Yanan Zhao (1 shared paper)Zhenhua Chen (1 shared paper)Hua Ye (1 shared paper)
- Journals
- Human Molecular Genetics (1 paper)Journal of Hematology & Oncology (1 paper)Frontiers in Oncology (1 paper)Breast Cancer Research (1 paper)PLoS Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSlovakia
In The Last Decade
Bo‐Wei Han
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Cancer Research 535
- Reproductive Medicine 128
- Obstetrics and Gynecology 94
- Molecular Biology 568
- Immunology 161
Countries citing papers authored by Bo‐Wei Han
This map shows the geographic impact of Bo‐Wei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Wei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Wei Han more than expected).
Fields of papers citing papers by Bo‐Wei Han
This network shows the impact of papers produced by Bo‐Wei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Wei Han. The network helps show where Bo‐Wei Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo‐Wei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 201 | |
| 2 | 2021 | 174 | |
| 3 | 2010 | 161 | |
| 4 | 2012 | 160 | |
| 5 | 2011 | 100 | |
| 6 | 2011 | 63 | |
| 7 | 2014 | 43 | |
| 8 | 2013 | 27 | |
| 9 | 2021 | 25 | |
| 10 | 2018 | 21 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 12 | |
| 13 | 2013 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2021 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 3 |
About Bo‐Wei Han
Bo‐Wei Han is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Cancer Genomics and Diagnostics (6 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers), DNA Repair Mechanisms (2 papers), Circular RNAs in diseases (2 papers), Single-cell and spatial transcriptomics (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (535 citations), Reproductive Medicine (128 citations), Obstetrics and Gynecology (94 citations), Molecular Biology (568 citations) and Immunology (161 citations). Bo‐Wei Han has collaborated with scholars based in China, United States and Slovakia. Frequent co-authors include Yujie Chen, Wentao Wang, Panpan Wei, Xingju Zhang, Hua Zhang, Yanan Zhao, Zhenhua Chen, Hua Ye, Ling Xu and Bo He. Their work appears in journals such as Human Molecular Genetics, Journal of Hematology & Oncology, Frontiers in Oncology, Breast Cancer Research and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.